| Cash Flows From Operating Activities | |
| Net income (loss) | 59.84M |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |
| Depreciation | 69.45M |
| Amortization of deferred financing costs | |
| Gains on sales of real estate assets, net | 0 |
| Other, net | |
| Asset impairment charges | |
| Equity in income of unconsolidated entities, net | -2.15M |
| Distributions of earnings of unconsolidated entities | 2.06M |
| Deferred compensation | |
| Stock-based compensation | 3.09M |
| Changes in assets, decrease (increase) in: | |
| Other assets | -3.39M |
| Deferred charges | |
| Changes in liabilities, increase (decrease) in: | |
| Accrued interest payable | 3.91M |
| Accounts payable and accrued expenses | 22.72M |
| Security deposits and prepaid rents | |
| Net cash provided by operating activities | |
| Cash Flows From Investing Activities | |
| Construction and acquisition of real estate assets, net of payables | |
| Net proceeds from sales of real estate assets | 0 |
| Capitalized interest | |
| Property capital expenditures | -28.56M |
| Corporate additions and improvements | -1.16M |
| Investments in and advances to unconsolidated entities | |
| Note receivable collections and other investments | |
| Net cash used in investing activities | |
| Cash Flows From Financing Activities | |
| Lines of credit proceeds | 334.09M |
| Lines of credit repayments | -270.23M |
| Payments on indebtedness | -2.27M |
| Payments of financing costs and other | 0 |
| Proceeds from sales of common stock | |
| Proceeds from employee stock purchase and stock options plans | 1.89M |
| Redemption of preferred stock | |
| Distributions to noncontrolling interests - real estate entities | |
| Distributions to noncontrolling interests - common unitholders | -166K |
| Dividends paid to preferred shareholders | -2.77M |
| Dividends paid to common shareholders | -74.05M |
| Net cash used in financing activities | |
| Net increase (decrease) in cash and cash equivalents | -23.55M |
| Cash and cash equivalents, beginning of period | 28.61M |
| Cash and cash equivalents, end of period | 5.06M |
| Cash Flows From Operating Activities | |
| Net income (loss) | 59.84M |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |
| Depreciation | 69.45M |
| Amortization of deferred financing costs | |
| Gains on sales of real estate assets, net | 0 |
| Other, net | |
| Asset impairment charges | |
| Equity in income of unconsolidated entities, net | -2.15M |
| Distributions of earnings of unconsolidated entities | 2.06M |
| Deferred compensation | |
| Stock-based compensation | 3.09M |
| Changes in assets, decrease (increase) in: | |
| Other assets | -3.39M |
| Deferred charges | |
| Changes in liabilities, increase (decrease) in: | |
| Accrued interest payable | 3.91M |
| Accounts payable and accrued expenses | 22.72M |
| Security deposits and prepaid rents | |
| Net cash provided by operating activities | |
| Cash Flows From Investing Activities | |
| Construction and acquisition of real estate assets, net of payables | |
| Net proceeds from sales of real estate assets | 0 |
| Capitalized interest | |
| Property capital expenditures | -28.56M |
| Corporate additions and improvements | -1.16M |
| Investments in and advances to unconsolidated entities | |
| Note receivable collections and other investments | |
| Net cash used in investing activities | |
| Cash Flows From Financing Activities | |
| Lines of credit proceeds | 334.09M |
| Lines of credit repayments | -270.23M |
| Payments on indebtedness | -2.27M |
| Payments of financing costs and other | 0 |
| Proceeds from employee stock purchase and stock options plans | 1.89M |
| Redemption of preferred stock | |
| Distributions to noncontrolling interests - real estate entities | |
| Distributions to noncontrolling interests - common unitholders | -166K |
| Dividends paid to preferred shareholders | -2.77M |
| Dividends paid to common shareholders | -74.05M |
| Net cash used in financing activities | |
| Net increase (decrease) in cash and cash equivalents | -23.55M |
| Cash and cash equivalents, beginning of period | 28.61M |
| Cash and cash equivalents, end of period | 5.06M |